trending Market Intelligence /marketintelligence/en/news-insights/trending/nupGvAKVQubthbsLy8fCgA2 content esgSubNav
In This List

Actinium Pharmaceuticals appoints CEO

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Actinium Pharmaceuticals appoints CEO

Actinium Pharmaceuticals Inc. appointed Sandesh Seth as its CEO.

Seth, who is also the company's chairman, will replace Kaushik Dave, who resigned May 12.

Seth is joined by Steve O'Loughlin, who was promoted to the position of principal financial and accounting officer from vice president of corporate finance and development.

Sergio Traversa resigned from the company's board.